SUVEN PHARMACEUTICALS LTD.
Smart Quotes
Trade Value (Rs. in Lacs) | 0.00 |
Dividend Yield(%) | 0.52 |
TTM EPS (Rs.) | 11.68 |
P/E Ratio | 41.33 |
Book Value (Rs.) | 36.49 |
Face Value (Rs.) | 1 |
MCap (Rs. in Mn) | 122942.15 |
Price/Earning (TTM) | 37.50 |
Price/Sales (TTM) | 13.14 |
Price/Book (MRQ) | 13.23 |
PAT Margin (%) | 32.39 |
ROCE (%) | 46.23 |
Management Info :
Venkateswarlu Jasti - Chairman Venkateswarlu Jasti - Managing DirectorRegistered Office :
Address :
#8-2-334 I, S D E Serene Chambers,6th Floor Road No. 5,Avenue 7, Banjara Hills ,
Hyderabad,
Telangana-500034
Phone : 040 - 2354 9414/ 3311/ 3315
Email : info@suvenpharm.com
Website : www.suvenpharm.com
QTR Dec 20 | ANNUAL 20 | |
---|---|---|
Net Profit | 976.35 | 2700.8 |
Gross Profit | 1315.09 | 3575.9 |
Operating Profit | 1429.99 | 4032.63 |
Net Sales | 2749.33 | 8337.9 |
Abbott India (BSE)![]() | M.Cap ( in Cr) 31011.55 |
Sanofi India (BSE)![]() | M.Cap ( in Cr) 19239.78 |
Astrazeneca Pharma I (BSE)![]() | M.Cap ( in Cr) 8776.25 |
Piramal Enterprises (BSE)![]() | M.Cap ( in Cr) 43979.97 |
Orchid Pharma (BSE)![]() | M.Cap ( in Cr) 4182.05 |
|
PROMOTERS | 60 % |
|
MUTUAL FUNDS/UTI | 3.29 % |
|
NON-INSTITUTION | 29.3 % |
|
FI/BANKS/INSURANCE | 0 % |
|
GOVERNMENT | 0 % |
|
FII | 0 % |
Scheme Name | Hold(%) |
---|---|
L&T Emerging Opp Fund-I... | 4.87 |
L&T Emerging Opp Fund-I... | 3.74 |
L&T Emerging Businesses... | 2.18 |
BOI AXA Flexi Cap Fund-... | 1.83 |
L&T Midcap Fund-Reg(G) | 1.60 |
BOI AXA Midcap Tax Fund... | 1.30 |